Intermed Xylojell

Lidocaine, the active ingredient in Intermed Xylojell, is a local anesthetic presented as a topical formulation for dental, endotracheopulmonary and laryngopharyngeal use. It provides rapid, reversible loss of sensation to facilitate minor surgical and diagnostic procedures in the oral cavity, airway and related structures.

GNH USA supplies Intermed Xylojell as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Intermed Xylojell is used to achieve local anesthesia in specific procedural areas.

Dental procedures: provides topical anesthesia to numb oral tissues during extractions, restorations and periodontal work. Endotracheopulmonary procedures: delivers surface anesthesia to the airway for bronchoscopy, intubation and related interventions. Laryngopharyngeal procedures: numbs the laryngeal and pharyngeal mucosa to facilitate examination and minor surgery.

Lidocaine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Burning sensation at the application site - Tingling or numbness beyond the intended area - Dizziness or light‑headedness

Serious or Rare Side Effects: - Seizures or convulsions - Cardiac arrhythmias, including ventricular tachycardia - Allergic reactions such as angioedema or anaphylaxis

When using Intermed Xylojell, consider the following precautions to minimize risk.

Assess patient allergy: verify no known lidocaine hypersensitivity. Avoid excessive application: limit dose to the recommended surface area. Monitor cardiac status: patients with heart block or arrhythmias need observation. Use with caution in hepatic impairment: reduced metabolism may increase toxicity. Avoid concurrent use of other local anesthetics: risk of cumulative toxicity. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Lidocaine can interact with several medicines; awareness of major and moderate interactions helps prevent adverse events.

Major Interactions (Avoid): - Class I antiarrhythmics (quinidine, procainamide): additive cardiac toxicity. - Other local anesthetics: cumulative sodium channel blockade. - Amiodarone: increased plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Cimetidine or erythromycin: moderate inhibition of metabolism. - Beta‑blockers (propranolol): may enhance bradycardia.